|
Ainm an Táirge:
|
Sulfáit pyrimidinetetramine |
| Comhchiallaigh: |
pyrimidineTetraylttraaminesulphate;
Pyrimidine-2,4,5,6-tetraminesulphate; 2,4,5,6-tetraaminiopyrimidinesulfate; 2,4,5,6 - tetraamino-pyrimidinesulfatealt;
2,4,5,6-tetraaminopyrimidinesulfatehydrate, 98%; 2,4,5,6-tetraaminopyrimidinesulfate;
6-tetraaminopyrimidinesulfate;
Pyrimidine-2,4,5,6-tetraaminesulfate
|
|
CAS:
|
5392-28-9 |
|
MF:
|
C4H10N6O4S |
|
MW:
|
238.22 |
| Einecs: | 226-393-0 |
Sulfáit pyrimidinetetramine
| Leáphointe | >300 céim (lit.) |
| Intuaslagthacht uisce | beagán intuaslagtha |
| Intuaslagthacht | DMSO (beag, le téamh), uisce (an -bheag, le téamh) |
| Gnáthnós | Púdar criostalach |
| Dath | Óir go donn |
|
Teocht stórála.
|
Séalaithe i dteocht tirim, teocht an tseomra |
Úsáid
|
Úsáid
|
2,4,5,6-Tetraaminopyrimidine sulfate is an intermediate for the synthesis of the antineoplastic drugs methotrexate and fludarabine.Methotrexate is a folate-based antineoplastic agent, mainly used for tumors such as acute leukemia, breast cancer, choriocarcinoma, and liver Taispeánann ailse, chomh maith le autoimmune - galair ghaolmhara lena n-áirítear diúltú trasphlandaithe post {-, dermatomyositis, agus lupus erythematosus.fludarabine sistéamach i gcóireáil leoicéime lymphocytic ainsealach B-chill.
|
Clibeanna Te: Pyrimidinetetramine Sulfáit CAS Uimh.
